Page last updated: 2024-09-22

dodecyldimethylamine oxide

Description

dodecyldimethylamine oxide: zwitterionic detergent [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

dodecyldimethylamine N-oxide : A tertiary amine oxide resulting from the formal oxidation of the amino group of dodecyldimethylamine. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID15433
CHEMBL ID1233973
CHEBI ID131762
SCHEMBL ID27337
MeSH IDM0063062

Synonyms (117)

Synonym
unii-4f6fc4mi8w
n,n-dimethyl-dodecylaminoxid
oxyde de dimethyllaurylamine
4f6fc4mi8w ,
refan
4-04-00-00798 (beilstein handbook reference)
ec 216-700-6
CHEMBL1233973 ,
n,n-dimethyl-1-dodecylamine n-oxide
n,n-dimethyldodecan-1-amine oxide
n,n-dimethyldodecylamine-n-oxide
1-dodecanamine, n,n-dimethyl-, n-oxide
dodecyl(dimethyl)amine oxide
n-lauryl-n,n-dimethylamine oxide
refan [russian]
n-lauryldimethylamine n-oxide
nci-c55129
brn 1769927
n,n-dimethyl-dodecylaminoxid [czech]
aromox dmmc-w
lauryl dimethyl amine oxide
1-dodecanamine, n,n-dimethl-, n-oxide
hsdb 5451
dodecylamine, n,n-dimethyl-, n-oxide
einecs 216-700-6
n,n-dimethyl-1-dodecanamine-n-oxide
amonyx ao
oxyde de dimethyllaurylamine [french]
lauryl dimethylamine-n-oxide
rhodamox l
admox 12
cyclomox l
barlox 12i
amine oxide, dodecyl(dimethyl)-
lauramine oxide
aromox dm 12d
ammonyx dmcd 40
oxamin lo
ammonyx ao
1-dodecanamine, n,n-dimethyl-, n-oxide (9ci)
amphitol 20n
rewominox l 408
dimethyllaurylamine oxide
conco xal
emcol lo
dimethyldodecylamine oxide
aromox dmcd
genaminox la
dimethylaurylamine oxide
oxidet dm 20
rhodamox lo
laurylamine oxide
emcol l
tomah ao 728
incromine oxide l
aromox dm 12d-w
aromox dm 12w
dodecyldimethylamine oxide
ammonyx lo
dimethyldodecylamine n-oxide
aromox dm 12dw(c)
ldao
dodecylamine, n,n-dimethyl-, n-oxide (6ci,8ci)
unisafe a-lm
n-dodecyldimethylamine oxide
schercamox dml
atlas cd 413
softamine l
1643-20-5
101cg
emal 20n
empigen ob
ammonyx c10 amine oxide
lauryldimethylamine oxide
ddno
lauryldimethylamine n-oxide
n,n-dimethyldodecylamine oxide
DB04147
dodecyldimethylamine n-oxide
NCGC00164286-01
n,n-dimethyldodecylamine n-oxide, bioxtra, >=99.0% (nt)
CHEBI:131762 ,
n,n-dimethyldodecan-1-amine n-oxide
bdbm50327308
n,n-dimethyldodecylamine n-oxide
FT-0689256
lauramine oxide [hsdb]
euroxide lo
lauramine oxide [inci]
lauramine oxide [ii]
n,n-dimethyl lauramine oxide
AKOS015904034
SCHEMBL27337
SYELZBGXAIXKHU-UHFFFAOYSA-N
lauryl dimethylamine oxide
imethylauroylamine oxide
lauryldimethylamineoxide
mfcd00002049
DTXSID1020514
J-521637
n,n-dimethyldodecylamine n-oxide, >=99% (titration)
D78505
J-010130
ldao, n,n-dimethyldodecylamine n-oxide, powder
Q6501952
lauryldimethylamine-n-oxide
CS-0185955
n,n-dimethyldodecyclamine n-oxide
n-dodecyl-n,n-dimethylamine n-oxide
stepsept pb-50
lauramine oxide (ii)
L0361
n,n-dimethyldodecylamine n-oxide (ca. 30% in water)
HY-W127785
n,n-dimethyldodecan-1-amine oxide, 30wt.% solution in h2o
SY073421
AKOS040744734

Roles (2)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
detergentA surfactant (or a mixture containing one or more surfactants) having cleaning properties in dilute solutions.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
tertiary amine oxideAn N-oxide where there are three organic groups bonded to the nitrogen atom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (7)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
pregnane X receptorRattus norvegicus (Norway rat)Potency50.11870.025127.9203501.1870AID651751
AR proteinHomo sapiens (human)Potency44.66840.000221.22318,912.5098AID588516
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency28.18380.000214.376460.0339AID588533
retinoid X nuclear receptor alphaHomo sapiens (human)Potency22.38720.000817.505159.3239AID588544
pregnane X nuclear receptorHomo sapiens (human)Potency50.11870.005428.02631,258.9301AID720659
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency41.46700.000627.21521,122.0200AID651741; AID720636
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Lanosterol synthaseHomo sapiens (human)IC50 (µMol)4.23000.00651.73966.3100AID516494; AID639307
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (4)

Processvia Protein(s)Taxonomy
steroid biosynthetic processLanosterol synthaseHomo sapiens (human)
cholesterol biosynthetic processLanosterol synthaseHomo sapiens (human)
triterpenoid biosynthetic processLanosterol synthaseHomo sapiens (human)
regulation of protein stabilityLanosterol synthaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (2)

Processvia Protein(s)Taxonomy
lanosterol synthase activityLanosterol synthaseHomo sapiens (human)
protein bindingLanosterol synthaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (3)

Processvia Protein(s)Taxonomy
endoplasmic reticulum membraneLanosterol synthaseHomo sapiens (human)
lipid dropletLanosterol synthaseHomo sapiens (human)
membraneLanosterol synthaseHomo sapiens (human)
lipid dropletLanosterol synthaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID639306Inhibition of human OSC expressed in Saccharomyces cerevisiae at 20 uM by gas chromatography2012Bioorganic & medicinal chemistry letters, Jan-01, Volume: 22, Issue:1
Inhibitors of human 2,3-oxidosqualene cyclase (OSC) discovered by virtual screening.
AID639305Inhibition of human OSC expressed in Saccharomyces cerevisiae at 20 uM by gas chromatography relative to LDAO22012Bioorganic & medicinal chemistry letters, Jan-01, Volume: 22, Issue:1
Inhibitors of human 2,3-oxidosqualene cyclase (OSC) discovered by virtual screening.
AID516494Inhibition of OSC2010Bioorganic & medicinal chemistry letters, Oct-01, Volume: 20, Issue:19
Novel pyrrole- and 1,2,3-triazole-based 2,3-oxidosqualene cyclase inhibitors.
AID599182Inhibition of anti-DNP-IgE-induced degranulation in rat RBL2H3 cells assessed as beta-hexosaminidase release at 25 uM after 30 mins by fluorescence assay2011European journal of medicinal chemistry, Jun, Volume: 46, Issue:6
Lipid-like sulfoxides and amine oxides as inhibitors of mast cell activation.
AID639307Inhibition of human OSC expressed in Saccharomyces cerevisiae by gas chromatography2012Bioorganic & medicinal chemistry letters, Jan-01, Volume: 22, Issue:1
Inhibitors of human 2,3-oxidosqualene cyclase (OSC) discovered by virtual screening.
AID516493Inhibition of OSC at 20 uM2010Bioorganic & medicinal chemistry letters, Oct-01, Volume: 20, Issue:19
Novel pyrrole- and 1,2,3-triazole-based 2,3-oxidosqualene cyclase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (122)

TimeframeStudies, This Drug (%)All Drugs %
pre-199021 (17.21)18.7374
1990's26 (21.31)18.2507
2000's37 (30.33)29.6817
2010's30 (24.59)24.3611
2020's8 (6.56)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (0.81%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other123 (99.19%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research Highlights

Dosage (1)

ArticleYear
A comparison of the elimination and biotransformation of dodecyldimethylamine oxide (DDAO) by rats, rabbits, and man.
Xenobiotica; the fate of foreign compounds in biological systems, Volume: 11, Issue: 7
1981
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Interactions (1)

ArticleYear
Toxicological evaluation of mixtures of nonionic surfactants, alone and in combination with oil.
Journal of pharmaceutical sciences, Volume: 92, Issue: 4
2003
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]